TARGETING LYSINE DEMETHYLASES (KDMs) AS A THERAPEUTIC STRATEGY FOR DIFFUSE LARGE B-CELL… Application EP-3630079-A4 European Patent Office 24 Feb 2021
TARGETING LYSINE DEMETHYLASES (KDMs) AS A THERAPEUTIC STRATEGY FOR DIFFUSE LARGE B-CELL… Application WO-2018222831-A1 World Intellectual Property Organisation (WIPO) 06 Dec 2018